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Racial stereotyping: survey of psychiatrists in the
United Kingdom
Helen Minnis, Alison McMillan, Marjorie Gillies, Shubulade Smith
Ten years ago, psychiatrists rated black male patients as
potentially more violent than white patients.1 We
aimed to establish whether such racial stereotyping still
occurs.
Participants, methods, and results
We sent a postal questionnaire concerning the first
presentation of a young man at casualty—which
included a photograph, brief history, and findings on
the patient’s mental state—to a random sample (gener›
ated by SPSS statistical software) of 1000 British
psychiatrists obtained from the Royal College of
Psychiatrists’ database. The sample was randomised so
that half received a picture of a black man and half
received a picture of a white man. (Photographs were
of one of four healthy volunteers, whom we had not
seen previously; they were matched for age and
occupation, and photographed under identical condi›
tions.) To exclude the possibility that results stemmed
from differences between individual photographs, such
as facial expression and mode of dress, we photo›
graphed two men from each race; one was a footballer
and the other an academic (the photographs can be
seen on BMJ ’s website). We used recommended termi›
nology for ethnicity.2 Respondents were asked to rank
five questions, in order of importance, to supplement
the assessment. ÷2 tests compared “black” with “white”
questionnaires after questions were grouped into
“important” (ranking 1›2) and “less important”
(ranking 3›5). Respondents rated questions on
management issues by putting a cross on a 10 cm con›
tinuous line. For each question, mean scores for “black”
and “white” questionnaires were compared using the
Mann›Whitney U test (table).
Of the 823 psychiatrists who could be contacted
(18% had changed address or retired), 59% (n = 485)—
equivalent to 10% of British psychiatrists—returned
completed questionnaires. Forty eight per cent (232)
had received a “black” questionnaire. Fourteen
respondents, who had all received a questionnaire with
a photograph of a black man, guessed the hypothesis;
six completed the questionnaire and were included in
the analyses. Five others returned questionnaires
uncompleted. Prior power calculations, based on
expected mean (SD) risks of violence of 2.41 (1.76) v
2.87 (1.53),1 gave the study 85% power at the 5% level.
Psychiatrists indicated that they were more likely to
ask black patients whether they had a social worker or
had received learning support at school, whereas they
were more likely to ask white patients about problem
drinking. They were equally likely to ask a black patient
or a white patient if they had a criminal record or had
recently used illegal drugs. Psychiatrists thought it
would be more difficult to build a rapport with white
patients, that white patients would be more of a
management problem, and that they were more likely
to pose a risk of violence to others. There were no sig›
nificant differences regarding risk to self, the need for
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inpatient care, or the need for a locked ward.
Psychiatrists were more likely to rate schizophrenia
and personality disorder as appropriate diagnoses for
white patients, but there were no differences for bipolar
illness or brief reactive psychosis (table). There were no
significant differences in any of the above variables
between patients of the same race.
Comment
Participating psychiatrists did not rate black patients as
more likely to be violent than white; this is different
from a decade ago.1 Did psychiatrists guess the hypoth›
esis and overcompensate? Only 1% suggested that they
had overcompensated (none with a “white” question›
naire); in addition, ranking of supplementary questions
in which psychiatrists with “black” photographs were
more likely to ask about social work or learning
support suggested that racial stereotyping was
occurring. Differences in management strategies were
small and may not be clinically important. Racism is
evident in the psychiatric system: involuntary admis›
sions of young black men are more common than
those of young white men,3 4 and schizophrenia is
more commonly diagnosed in young black men4 even
though the prevalence in the community is no
different for black and white men.5 Our results suggest
that the racial stereotyping that occurs at first interview
is not sufficient to account for the inequalities seen in
secondary care. Urgent exploration is required to find
out where these inequalities arise.
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Differences between “black” and “white” questionnaires completed by British psychiatrists in ranking of questions on a 10 cm
continuous line. Values are means (SD) unless otherwise stated
Item on questionnaire Black (n=232) White (n=253) Test statistic (95% CI)* P value
Question likely to be asked of subject (%)†:
Had a social worker n=72/231 (31) n=47/227 (21) ÷2=6.52 (0.02 to 0.18) 0.01
Had learning support n=24/231 (10) n=13/227 (6) ÷2=3.35 (−0.003 to 0.10) 0.06
Had a drinking problem n=106/231 (46) n=140/227 (62) ÷2=11.47 (−0.25 to −0.07) 0.001
Had a criminal record n=38/231 (16) n=35/227 (15) ÷2=0.09 (−0.06 to 0.08) 0.80
Had recently used illegal drugs n=224/232 (96) n=219/227 (96) ÷2=0.002 (−0.03 to 0.03) 0.90
Rapport difficult to establish 62.4 (18.3) 68.4 (16.2) 23577.5 (−9.00 to −2.80) 0.01
Management problem 61.7 (16.1) 66.9 (16.6) 22139.0 (−8.10 to −2.20) 0.001
Risk of violence to others 52.6 (20.4) 57.8 (19.9) 63.5 (−8.80 to −1.55) 0.005
Likely diagnosis:
Schizophrenia 77.8 (17.3) 83.0 (13.5) 3500.5 (−8.00 to −2.40) <0.0001
Personality disorder 29.0 (18.3) 36.6 (21.0) 1408.5 (−11.20 to −4.00) <0.0001
Bipolar illness 50.7 (21.4) 48.6 (22.0) 26037.0 (−1.84 to 6.00) 0.29
Brief reactive psychosis 65.9 (20.8) 62.8 (23.1) 6308.5 (−0.90 to 7.00) 0.13
Neuroleptic drug indicated 86.7 (12.2) 89.9 (11.24) 3575.0 (−5.30 to −1.10) 0.003
*Mann›Whitney U unless otherwise stated. †Not all questions were ranked by all psychiatrists.
One hundred years ago
Nurses for the middle classes
A correspondent writing to us on the occasion of the
presentation of the Queen Victoria Jubilee Nurses, remarks that
“the whole scheme of nursing appears to have been developed
to the advantage of two classes, the very rich and the very poor,”
and goes on to point out the difficulty of meeting the nursing
cost of a severe or long illness with a moderate income. We quite
agree with the writer; the middle classes are in this as in many
other points at serious disadvantage, but we confess that we do
not see from whence a remedy is to come. Of the many plans
which have been tried, the only one that has survived is the
nursing of the middle classes on the same lines as that of the
district nurses, by means of the “visiting” or “daily” nurse, the
fees being arranged on such a scale as, given a sufficiency of
patients, the nurse is properly remunerated. In the case of many
forms of illness this attendance is sufficient, but when the
patient’s condition is very grave, more continuous nursing is
required and the expenditure is increased. Another scheme that
has been tried is the hospital for the middle classes, but with the
high rents and taxes and the cost of living it has been found
impossible to work such a hospital on a small scale at fees within
the reach of the patient, and there are other objections to this
plan which need not now be particularised. The nurse’s fee of
two guineas a week, though it sounds high, is only sufficient to
keep her during her short period of earning, and leaves very
little for old age or sickness.
(BMJ 1901;ii:162)
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